Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Top Cited Papers
- 2 June 2020
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 172 (11) , 754-755
- https://doi.org/10.7326/m20-1334
Abstract
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019. The authors of this commentary provide guidance for clinical decision making for patients with coronavirus disease 2019 as well as for patients with rheumatologic conditions, such as systemic lupus erythematosus and rheumatoid arthritisFunding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR070155, K24AR074534)
This publication has 10 references indexed in Scilit:
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19Annals of Internal Medicine, 2020
- 硫酸羟氯喹治疗2019冠状病毒病(COVID-19)普通型患者的初步研究2020
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitroCell Discovery, 2020
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatologyNature Reviews Rheumatology, 2020
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trialThe Lancet Infectious Diseases, 2011
- Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosusArthritis & Rheumatism, 2006
- In vitro inhibition of human influenza A virus replication by chloroquineVirology Journal, 2006
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusNew England Journal of Medicine, 1991